Factors to Consider When Choosing the Right Disease-Modifying Therapy for Newly Diagnosed MS

Gabrielle Macaron, MD, assistant professor of neuroscience at Université de Montréal, discussed the nuanced clinical decision-making involved in initiating a DMT for patients newly diagnosed with MS.